 - Subject requires treatment with concomitant drugs that target serotonin 5-hydroxytryptamine receptor 1 5HT1R or 5-hydroxytryptamine receptor 2B 5HT2BR or sigma nonspecific receptor with the exception of drugs that are considered absolutely essential for the care of the subject. 